Persistence of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Clones in a Subject with Rapid Disease Progression

Por Islam, Sabina A., Hay, Christine M., Hartman, Kelly E., He, Suqin, Shea, Amy K., Trocha, Alicja K., Dynan, Mark J., Reshamwala, Neha, Buchbinder, Susan P., Basgoz, Nesli O., Kalams, Spyros A.
Publicado em 2001

DNA and Modified Vaccinia Virus Ankara Vaccines Encoding Multiple Cytotoxic and Helper T-Lymphocyte Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) Are Safe but Weakly Immu...

Por Gorse, Geoffrey J., Newman, Mark J., deCamp, Allan, Hay, Christine Mhorag, De Rosa, Stephen C., Noonan, Elizabeth, Livingston, Brian D., Fuchs, Jonathan D., Kalams, Spyros A., Cassis-Ghavami, Farah L.
Publicado em 2012

Lack of Viral Escape and Defective In Vivo Activation of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes in Rapidly Progressive Infection

Por Hay, Christine M., Ruhl, Debbie J., Basgoz, Nesli O., Wilson, Cara C., Billingsley, James M., DePasquale, Maria Pia, D’Aquila, Richard T., Wolinsky, Steven M., Crawford, John M., Montefiori, David C., Walker, Bruce D.
Publicado em 1999

Safety and Immunogenicity of IMVAMUNE® Smallpox Vaccine Using Different Strategies for a Post Event Scenario

Por Frey, Sharon E., Winokur, Patricia L., Salata, Robert A., El-Kamary, Samer S., Turley, Christine B., Walter, Emmanuel B., Hay, Christine Mhorag, Newman, Frances K., Hill, Heather R., Zhang, Ying, Chaplin, Paul, Tary-Lehmann, Magdalena, Belshe, Robert B.
Publicado em 2013

A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old S...

Por Greenberg, Richard N., Hay, Christine M., Stapleton, Jack T., Marbury, Thomas C., Wagner, Eva, Kreitmeir, Eva, Röesch, Siegfried, von Krempelhuber, Alfred, Young, Philip, Nichols, Richard, Meyer, Thomas P., Schmidt, Darja, Weigl, Josef, Virgin, Garth, Arndtz-Wiedemann, Nathaly, Chaplin, Paul
Publicado no PLoS One (2016)

Efficient Processing of the Immunodominant, HLA-A*0201-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitope despite Multiple Variations in the Epitope Flan...

Por Brander, Christian, Yang, Otto O., Jones, Norman G., Lee, Yun, Goulder, Philip, Johnson, R. Paul, Trocha, Alicja, Colbert, David, Hay, Christine, Buchbinder, Susan, Bergmann, Cornelia C., Zweerink, Hans J., Wolinsky, Steven, Blattner, William A., Kalams, Spyros A., Walker, Bruce D.
Publicado em 1999

Comparison of the Immunogenicity and Safety of a Split-virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal or Intramuscular Route in Healthy Adu...

Por Frenck, Robert W., Belshe, Robert, Brady, Rebecca C, Winokur, Patricia L., Campbell, James D., Treanor, John, Hay, Christine M., Dekker, Cornelia L., Walter, Emmanuel B., Cate, Thomas R., Edwards, Kathryn M., Hill, Heather, Wolff, Mark, LeDuc, Tom, Tornieporth, Nadia
Publicado em 2011

Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia...

Por Buchbinder, Susan P., Grunenberg, Nicole A., Sanchez, Brittany J., Seaton, Kelly E., Ferrari, Guido, Moody, M. Anthony, Frahm, Nicole, Montefiori, David C., Hay, Christine M., Goepfert, Paul A., Baden, Lindsey R., Robinson, Harriet L., Yu, Xuesong, Gilbert, Peter B., McElrath, M. Juliana, Huang, Yunda, Tomaras, Georgia D.
Publicado no PLoS One (2017)

Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

Por Goepfert, Paul A., Elizaga, Marnie L., Sato, Alicia, Qin, Li, Cardinali, Massimo, Hay, Christine M., Hural, John, DeRosa, Stephen C., DeFawe, Olivier D., Tomaras, Georgia D., Montefiori, David C., Xu, Yongxian, Lai, Lilin, Kalams, Spyros A., Baden, Lindsey R., Frey, Sharon E., Blattner, William A., Wyatt, Linda S., Moss, Bernard, Robinson, Harriet L.
Publicado em 2011

Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine i...

Por Elizaga, Marnie L., Li, Shuying S., Kochar, Nidhi K., Wilson, Gregory J., Allen, Mary A., Tieu, Hong Van N., Frank, Ian, Sobieszczyk, Magdalena E., Cohen, Kristen W., Sanchez, Brittany, Latham, Theresa E., Clarke, David K., Egan, Michael A., Eldridge, John H., Hannaman, Drew, Xu, Rong, Ota-Setlik, Ayuko, McElrath, M. Juliana, Hay, Christine Mhorag
Publicado no PLoS One (2018)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

Por Keefer, Michael C., Gilmour, Jill, Hayes, Peter, Gill, Dilbinder, Kopycinski, Jakub, Cheeseman, Hannah, Cashin-Cox, Michelle, Naarding, Marloes, Clark, Lorna, Fernandez, Natalia, Bunce, Catherine A., Hay, Christine M., Welsh, Sabrina, Komaroff, Wendy, Hachaambwa, Lottie, Tarragona-Fiol, Tony, Sayeed, Eddy, Zachariah, Devika, Ackland, James, Loughran, Kelley, Barin, Burc, Cormier, Emmanuel, Cox, Josephine H., Fast, Patricia, Excler, Jean-Louis
Publicado em 2012

DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8(+) T-Cell Responses by Interleukin-12 Plasmid DNA

Por Li, Shuying S., Kochar, Nidhi K., Elizaga, Marnie, Hay, Christine M., Wilson, Gregory J., Cohen, Kristen W., De Rosa, Stephen C., Xu, Rong, Ota-Setlik, Ayuko, Morris, Daryl, Finak, Greg, Allen, Mary, Tieu, Hong-Van, Frank, Ian, Sobieszczyk, Magdalena E., Hannaman, Drew, Gottardo, Raphael, Gilbert, Peter B., Tomaras, Georgia D., Corey, Lawrence, Clarke, David K., Egan, Michael A., Eldridge, John H., McElrath, M. Juliana, Frahm, Nicole
Publicado no Clin Vaccine Immunol (2017)